Sudthida Vasavanonda

3.1k citations

26 papers · 2.2k · 1 hit paper · h-index 15

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 18
- HIV Research and Treatment 18
Infectious Diseases 25
- HIV/AIDS drug development and treatment 25
- HIV/AIDS Research and Interventions 2

Co-authors: Dale J. Kempf (23 shared papers)Daniel W. Norbeck (20 shared papers)Akhteruzzaman Molla (5 shared papers)Norman E. Wideburg (13 shared papers)John M. Leonard (2 shared papers)Ann Hsu (3 shared papers)Hongmei Mo (3 shared papers)Ayda C. Saldivar (17 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (11 papers)Antimicrobial Agents and Chemotherapy (4 papers)Journal of Medicinal Chemistry (3 papers)Biochemical and Biophysical Research Communications (2 papers)Nature Medicine (1 paper)
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Sudthida Vasavanonda

26 papers receiving 2.0k citations

Sudthida Vasavanonda's Hit Papers

align trajectories log scale

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir 1996 · 641 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

1996 Nature Medicine

Peers

Countries citing papers authored by Sudthida Vasavanonda

Since Specialization

Citations

This map shows the geographic impact of Sudthida Vasavanonda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sudthida Vasavanonda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sudthida Vasavanonda more than expected).

Fields of papers citing papers by Sudthida Vasavanonda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sudthida Vasavanonda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sudthida Vasavanonda. The network helps show where Sudthida Vasavanonda may publish in the future.

Co-authors

The 25 scholars most cited alongside Sudthida Vasavanonda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sudthida Vasavanonda Line = papers co-authored together Sudthida Vasavanonda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Ordered accumulation of mutations in HIV protease confers resistance to ritonavir Nature Medicine ·Akhteruzzaman Molla, Marina Korneyeva, Qing Chun Gao, Sudthida Vasavanonda, Paaline J. Schipper, Hongmei Mo, Martin H. Markowitz, Tatyana Chernyavskiy Hit paper breakdown →	1996	641
2	ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease Antimicrobial Agents and Chemotherapy ·Hing Leung Sham, Dale J. Kempf, Akhteruzammen Molla, Kennan C. Marsh, Gondi N. Kumar, Chih‐Ming Chen, Warren M. Kati, Kent D. Stewart	1998	401
3	Structure-based, C2 symmetric inhibitors of HIV protease Journal of Medicinal Chemistry ·Dale J. Kempf, Daniel W. Norbeck, LynnMarie Codacovi, Xiu Chun Wang, William E. Kohlbrenner, Norman E. Wideburg, Deborah A. Paul, Mark F. Knigge	1990	190
4	Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus Virology ·Akhteruzzaman Molla, Sudthida Vasavanonda, Gondi N. Kumar, Hing Leung Sham, Marianne K. Johnson, Brian A. Grabowski, Jon F. Denissen, William E. Kohlbrenner	1998	165
5	Discovery of Ritonavir, a Potent Inhibitor of HIV Protease with High Oral Bioavailability and Clinical Efficacy Journal of Medicinal Chemistry ·Dale J. Kempf, Hing Leung Sham, Kennan C. Marsh, Charles A. Flentge, David A. Betebenner, Brian E. Green, Edith J. McDonald, Sudthida Vasavanonda	1998	161
6	Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease Antimicrobial Agents and Chemotherapy ·Dale J. Kempf, Kennan C. Marsh, Deborah A. Paul, Mark F. Knigge, Daniel W. Norbeck, W E Kohlbrenner, L Codacovi, Sudthida Vasavanonda	1991	124
7	Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diol Journal of Medicinal Chemistry ·Dale J. Kempf, L Codacovi, X C Wang, W E Kohlbrenner, Norman E. Wideburg, Ayda C. Saldivar, Sudthida Vasavanonda, Kennan C. Marsh	1993	119
8	In Vitro Antiviral Interaction of Lopinavir with Other Protease Inhibitors Antimicrobial Agents and Chemotherapy ·Akhteruzzaman Molla, Hongmei Mo, Sudthida Vasavanonda, C. Thomas Lin, Ann Hsu, Dale J. Kempf +1 other	2002	47
9	Design of orally bioavailable, symmetry-based inhibitors of HIV protease Bioorganic & Medicinal Chemistry ·Dale J. Kempf, Kennan C. Marsh, Lynnmarie Codacovi Fino, Pamela Bryant, Adrienne C. Craig-Kennard, Hing Leung Sham, Chen Zhao, Sudthida Vasavanonda	1994	44
10	Mechanistic Study of HCV Polymerase Inhibitors at Individual Steps of the Polymerization Reaction Biochemistry ·Yaya Liu, Wen Jiang, John K. Pratt, Todd W. Rockway, Kevin S. Harris, Sudthida Vasavanonda, Rakesh L. Tripathi, Ron B. Pithawalla	2006	43
11	Novel lopinavir analogues incorporating non-Aromatic P-1 side chains—Synthesis and structure–Activity relationships Bioorganic & Medicinal Chemistry Letters ·Hing Leung Sham, Chen Zhao, Leping Li, David A. Betebenner, Ayda C. Saldivar, Sudthida Vasavanonda, Dale J. Kempf, Jacob J. Plattner	2002	41
12	Estimation of Serum-Free 50-Percent Inhibitory Concentrations for Human Immunodeficiency Virus Protease Inhibitors Lopinavir and Ritonavir Antimicrobial Agents and Chemotherapy ·Dean Hickman, Sudthida Vasavanonda, George Nequist, Lynn M. Colletti, Warren M. Kati, Richard Bertz, Ann Hsu, Dale J. Kempf	2004	29
13	Potent HIV-1 protease inhibitors with antiviral activities in vitro Biochemical and Biophysical Research Communications ·Hing Leung Sham, David A. Betebenner, Norman E. Wideburg, Ayda C. Saldivar, William E. Kohlbrenner, Sudthida Vasavanonda, Dale J. Kempf, Daniel W. Norbeck	1991	18
14	Synthesis and SAR studies of potent HIV protease inhibitors containing novel dimethylphenoxyl acetates as P2 ligands Bioorganic & Medicinal Chemistry Letters ·Xiaoqi Chen, Dale J. Kempf, Lin Li, Hing Leung Sham, Sudthida Vasavanonda, Norman E. Wideburg, Ayda C. Saldivar, Kennan C. Marsh	2003	18
15	Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strains Bioorganic & Medicinal Chemistry Letters ·Chen Zhao, Hing Leung Sham, Minghua Sun, Vincent S. Stoll, Kent D. Stewart, Shuqun Lin, Hongmei Mo, Sudthida Vasavanonda	2005	18
16	Synthesis and antiviral activities of the major metabolites of the HIV protease inhibitor ABT-378 (Lopinavir) Bioorganic & Medicinal Chemistry Letters ·Hing Leung Sham, David A. Betebenner, Thomas R. Herrin, Gondi N. Kumar, Ayda C. Saldivar, Sudthida Vasavanonda, Akhter Molla, Dale J. Kempf	2001	15
17	Synthesis and structure–activity relationships of a novel series of HIV-1 protease inhibitors encompassing ABT-378 (Lopinavir) Bioorganic & Medicinal Chemistry Letters ·Hing Leung Sham, David A. Betebenner, Xiaoqi Chen, Ayda C. Saldivar, Sudthida Vasavanonda, Dale J. Kempf, Jacob J. Plattner, Daniel W. Norbeck	2002	15
18	Novel lopinavir analogues incorporating heterocyclic replacements of six-member cyclic urea––synthesis and structure–activity relationships Bioorganic & Medicinal Chemistry Letters ·Hing Leung Sham, David A. Betebenner, William Rosenbrook, Thomas R. Herrin, Ayda C. Saldivar, Sudthida Vasavanonda, Jacob J. Plattner, Daniel W. Norbeck	2004	15
19	Pseudo‐symmetrical difluoroketones FEBS Letters ·Hing Leung Sham, David A. Betebenner, Norman E. Wideburg, Ayda C. Saldivar, William E. Kohlbrenner, Adrienne C. Craig-Kennard, Sudthida Vasavanonda, Dale J. Kempf	1993	14
20	Synthesis and antiviral activity of P1′ arylsulfonamide azacyclic urea HIV protease inhibitors Bioorganic & Medicinal Chemistry Letters ·Peggy Huang, John T. Randolph, Larry L. Klein, Sudthida Vasavanonda, Tatyana Dekhtyar, Vincent S. Stoll, Dale J. Kempf	2004	11

About Sudthida Vasavanonda

Sudthida Vasavanonda is a scholar working on Virology, Infectious Diseases, Organic Chemistry, Hepatology and Epidemiology, having authored 26 papers that have together received 2.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (18 papers), Click Chemistry and Applications (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Biochemical and Molecular Research (5 papers), Hepatitis C virus research (5 papers), HIV/AIDS Research and Interventions (2 papers) and Synthesis and biological activity (1 paper). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (1.6k citations), Hepatology (182 citations), Emergency Medicine (169 citations) and Organic Chemistry (465 citations). Sudthida Vasavanonda has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Dale J. Kempf, Daniel W. Norbeck, Akhteruzzaman Molla, Norman E. Wideburg, John M. Leonard, Ann Hsu, Hongmei Mo, Ayda C. Saldivar, Kennan C. Marsh and Hing Leung Sham. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Antimicrobial Agents and Chemotherapy, Journal of Medicinal Chemistry, Biochemical and Biophysical Research Communications and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Sudthida Vasavanonda

Impact in

Papers in i

In The Last Decade

Sudthida Vasavanonda

Sudthida Vasavanonda's Hit Papers

Peers

Countries citing papers authored by Sudthida Vasavanonda

Fields of papers citing papers by Sudthida Vasavanonda

All Works

About Sudthida Vasavanonda

Explore authors with similar magnitude of impact

Papers in